BOLT 发表于 2025-3-23 12:41:41

Submitted on: 24 January 2020.
Revised on: 01 March 2020.
Accepted on: 21 March 2020.

___________________Current Cancer Therapy Reviews

synovitis 发表于 2025-3-23 16:39:57

Submitted on: 24 June 1998.
Revised on: 05 October 1998.
Accepted on: 28 October 1998.

___________________Current Cancer Therapy Reviews

Scleroderma 发表于 2025-3-23 21:24:12

Submitted on: 12 July 2010.
Revised on: 13 August 2010.
Accepted on: 12 September 2010.

___________________Current Cancer Therapy Reviews

Neutral-Spine 发表于 2025-3-23 22:50:38

http://reply.papertrans.cn/1/69/6860/6860-14.png

Boycott 发表于 2025-3-24 05:50:36

http://reply.papertrans.cn/1/69/6860/6860-15.png

上下倒置 发表于 2025-3-24 09:31:45

http://reply.papertrans.cn/1/69/6860/6860-16.png

失望昨天 发表于 2025-3-24 11:50:04

Submitted on: 12 January 2019.
Revised on: 19 April 2019.
Accepted on: 13 May 2019.

___________________Current Cancer Therapy Reviews

送秋波 发表于 2025-3-24 16:41:35

http://reply.papertrans.cn/1/69/6860/6860-18.png

帐单 发表于 2025-3-24 22:24:44

Submitted on: 01 January 2014.
Revised on: 15 March 2014.
Accepted on: 14 May 2014.

___________________Current Cancer Therapy Reviews

娴熟 发表于 2025-3-25 02:26:16

http://reply.papertrans.cn/1/69/6860/6860-20.png
页: 1 [2] 3 4
查看完整版本: ESCI期刊Current Cancer Therapy Reviews 2024/2025影响因子:0.483 (CURR CANCER THER REV) (1573-3947). (ONCOLOGY)(肿瘤学)Emerging So